A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)
Status: | Recruiting |
---|---|
Conditions: | Lung Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - 100 |
Updated: | 12/23/2018 |
Start Date: | March 21, 2018 |
End Date: | January 31, 2020 |
Contact: | Robyn Swing |
Email: | Robyn.swing@ucdenver.edu |
Phone: | 720-848-0607 |
To evaluate the correlation between pre-surgical 4DCT-ventilation imaging and post-surgical
lung function.
lung function.
To evaluate the correlation between pre-surgical 4-Dimensional Computed
Tomography-ventilation (4DCT-ventilation) imaging and post-surgical lung function. To
determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than
nuclear medicine imaging using pulmonary function tests (PFTs). To determine whether
4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine
imaging using quality of life (QOL) questionnaires. Evaluate cost-effectiveness of using
4DCT-ventialtion and VQ scans for pre-surgical assessment. To use longitudinal (pre and
post-surgical) 4DCT-ventilation imaging to derive novel post-surgical prediction formulas.
Tomography-ventilation (4DCT-ventilation) imaging and post-surgical lung function. To
determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than
nuclear medicine imaging using pulmonary function tests (PFTs). To determine whether
4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine
imaging using quality of life (QOL) questionnaires. Evaluate cost-effectiveness of using
4DCT-ventialtion and VQ scans for pre-surgical assessment. To use longitudinal (pre and
post-surgical) 4DCT-ventilation imaging to derive novel post-surgical prediction formulas.
Inclusion Criteria:
1. Provision to sign and date the consent form.
2. Stated willingness to comply with all required (non-optional) study procedures and be
available for the duration of the study.
3. Be a male or female aged 18 to 100.
4. Patient with lung cancer (presumed or biopsy proven) undergoing evaluation for
resection.
5. Lung function assessment required for pre-surgical evaluation at the discretion of the
cardiothoracic surgeon.
6. Life expectancy greater than 3 months.
Exclusion Criteria:
1. Patients getting a planned wedge resection as the only thoracic resectional procedure.
We found this trial at
2
sites
1400 E Boulder St
Colorado Springs, Colorado 80909
Colorado Springs, Colorado 80909
Principal Investigator: Matthew Blum, MD
Phone: 719-365-2406
Click here to add this to my saved trials
13001 E. 17th Pl
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
Principal Investigator: Yevgeniy Vinogradskiy, PhD
Phone: 720-848-0607
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
Click here to add this to my saved trials